VANCOUVER, BC – Tekmira Pharmaceuticals Corporation (TSX: TKM), a leading developer of RNA interference (RNAi) therapeutics and proprietary delivery technology, announced today that it will hold a conference call and webcast on Thursday November 12, 2009 at 1:30 pm Pacific Time (4:30 pm Eastern Time) to discuss third quarter 2009 operating results and to provide a corporate update.

About the Conference Call
To participate in the conference call, please dial 416-695-6617 or 1-800-355-4959. The call will be available for replay until November 26, 2009 by calling 416-695-5800 or 1-800-408-3053 and entering the code 2875305.

The live or archived webcast can also be accessed through the Company’s website at www.tekmirapharm.com.

About Tekmira
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Further information about Tekmira can be found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.

Contact Information for Tekmira Pharmaceuticals Corporation

Investors
Adam Peeler
The Equicom Group
Phone: 416-815-0700 x 225
Email: apeeler@equicomgroup.com

Ian Mortimer
Executive Vice President and Chief Financial Officer
Phone: 604-419-3200

Media
David Ryan
Longview Communications Inc.
Phone: 604-694-6031
Email: dryan@longviewcomms.ca